These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. An Update on Natural Antileishmanial Treatment Options from Plants, Fungi and Algae. Koko WS; Al Nasr IS; Khan TA; Schobert R; Biersack B Chem Biodivers; 2022 Jan; 19(1):e202100542. PubMed ID: 34822224 [TBL] [Abstract][Full Text] [Related]
8. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives. Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823 [TBL] [Abstract][Full Text] [Related]
9. Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis. Lorente SO; Rodrigues JC; Jiménez Jiménez C; Joyce-Menekse M; Rodrigues C; Croft SL; Yardley V; de Luca-Fradley K; Ruiz-Pérez LM; Urbina J; de Souza W; González Pacanowska D; Gilbert IH Antimicrob Agents Chemother; 2004 Aug; 48(8):2937-50. PubMed ID: 15273104 [TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets. Vermelho AB; Capaci GR; Rodrigues IA; Cardoso VS; Mazotto AM; Supuran CT Bioorg Med Chem; 2017 Mar; 25(5):1543-1555. PubMed ID: 28161253 [TBL] [Abstract][Full Text] [Related]
11. Squalamine analogues as potential anti-trypanosomal and anti-leishmanial compounds. Khabnadideh S; Tan CL; Croft SL; Kendrick H; Yardley V; Gilbert IH Bioorg Med Chem Lett; 2000 Jun; 10(11):1237-9. PubMed ID: 10866389 [TBL] [Abstract][Full Text] [Related]
12. Microorganisms as a Potential Source of Molecules to Control Trypanosomatid Diseases. Chan-Bacab MJ; Reyes-Estebanez MM; Camacho-Chab JC; Ortega-Morales BO Molecules; 2021 Mar; 26(5):. PubMed ID: 33806654 [TBL] [Abstract][Full Text] [Related]
13. In vitro antiprotozoal activity of (S)-cis-Verbenol against Leishmania spp. and Trypanosoma cruzi. Yaluff G; Vega C; Alvarenga N Acta Trop; 2017 Apr; 168():41-44. PubMed ID: 28062234 [TBL] [Abstract][Full Text] [Related]
14. The Widespread Anti-Protozoal Action of HIV Aspartic Peptidase Inhibitors: Focus on Plasmodium spp., Leishmania spp. and Trypanosoma cruzi. Santos AL; d'Avila-Levy CM; Kneipp LF; Sodré CL; Sangenito LS; Branquinha MH Curr Top Med Chem; 2017; 17(11):1303-1317. PubMed ID: 27784256 [TBL] [Abstract][Full Text] [Related]
15. Triclosan-caffeic acid hybrids: Synthesis, leishmanicidal, trypanocidal and cytotoxic activities. Otero E; García E; Palacios G; Yepes LM; Carda M; Agut R; Vélez ID; Cardona WI; Robledo SM Eur J Med Chem; 2017 Dec; 141():73-83. PubMed ID: 29028533 [TBL] [Abstract][Full Text] [Related]
16. Natural products from plants as drug candidates and lead compounds against leishmaniasis and trypanosomiasis. Salem MM; Werbovetz KA Curr Med Chem; 2006; 13(21):2571-98. PubMed ID: 17017912 [TBL] [Abstract][Full Text] [Related]
17. An assessment on the role of endophytic microbes in the therapeutic potential of Fagonia indica. Rahman L; Shinwari ZK; Iqrar I; Rahman L; Tanveer F Ann Clin Microbiol Antimicrob; 2017 Aug; 16(1):53. PubMed ID: 28764775 [TBL] [Abstract][Full Text] [Related]
18. SAR studies on azasterols as potential anti-trypanosomal and anti-leishmanial agents. Gigante F; Kaiser M; Brun R; Gilbert IH Bioorg Med Chem; 2009 Aug; 17(16):5950-61. PubMed ID: 19620005 [TBL] [Abstract][Full Text] [Related]
19. Potential therapeutic use of herbal extracts in trypanosomiasis. Teixeira TL; Teixeira SC; da Silva CV; de Souza MA Pathog Glob Health; 2014 Jan; 108(1):30-6. PubMed ID: 24548158 [TBL] [Abstract][Full Text] [Related]
20. The use of Sulfonamide Derivatives in the Treatment of Trypanosomatid Parasites including Trypanosoma cruzi, Trypanosoma brucei, and Leishmania ssp. Scarim CB; Chelucci RC; Dos Santos JL; Chin CM Med Chem; 2020; 16(1):24-38. PubMed ID: 31218962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]